SEVERANCE WAIVERSeverance Waiver • May 10th, 2022 • Lyell Immunopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMay 10th, 2022 Company IndustryTHIS SEVERANCE WAIVER (the “Agreement”) is made and entered into by and between Stephen Hill (“Executive”) and Lyell Immunopharma, Inc. (the “Company”), effective as of April 19, 2022.